Published in J Am Chem Soc on March 19, 1975
Synthesis and properties of oligonucleotides containing aminodeoxythymidine units. Nucleic Acids Res (1992) 1.74
Methylphosphonates as probes of protein-nucleic acid interactions. Nucleic Acids Res (1984) 1.49
Forks and combs and DNA: the synthesis of branched oligodeoxyribonucleotides. Nucleic Acids Res (1989) 1.44
Synthesis of well-defined phosphate-methylated DNA fragments: the application of potassium carbonate in methanol as deprotecting reagent. Nucleic Acids Res (1990) 1.17
The application of the AMB protective group in the solid-phase synthesis of methylphosphonate DNA analogues. Nucleic Acids Res (1993) 0.88
Convenient synthesis of a propargylated cyclic (3'-5') diguanylic acid and its "click" conjugation to a biotinylated azide. Bioconjug Chem (2010) 0.82
Electron injection from the side of an M-DNA duplex. J Biol Inorg Chem (2005) 0.79
Synthesis of riboguanosine pentaphosphate ppprGpp (Magic Spot II) via a phosphotriester approach. Nucleic Acids Res (1985) 0.78
Design and synthesis of vidarabine prodrugs as antiviral agents. Bioorg Med Chem Lett (2008) 0.77
5'-O-D-valyl ara A, a potential prodrug for improving oral bioavailability of the antiviral agent vidarabine. Nucleosides Nucleotides Nucleic Acids (2009) 0.77
Selective oxidation of methionine residues in proteins. Biochemistry (1975) 2.03
Cyanylation of sulfhydryl groups by 2-nitro-5-thiocyanobenzoic acid. High-yield modification and cleavage of peptides at cysteine residues. Biochemistry (1974) 1.44
Selective chemical cleavage of tryptophanyl peptide bonds by oxidative chlorination with N-chlorosuccinimide. Biochemistry (1976) 1.43
Development of polyacrylamide gels that improve the separation of proteins and their detection by silver staining. Anal Biochem (1988) 1.38
Genetic linkage of Werner's syndrome to five markers on chromosome 8. Nature (1992) 1.37
An electrophilic mechanism in the chymotrypsin-catalyzed hydrolysis of anilide substrates. J Am Chem Soc (1965) 1.16
Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int (1995) 1.15
Impaired monocyte function in liver cirrhosis. Br Med J (Clin Res Ed) (1981) 1.13
Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists. J Med Chem (1997) 1.09
Selective cyanylation of sulfhydryl groups. J Am Chem Soc (1970) 1.06
Lack of cross-reactivity between aztreonam , a monobactam antibiotic, and penicillin in penicillin-allergic subjects. J Infect Dis (1984) 1.05
Selective cleavage and modification of peptides and proteins. Adv Protein Chem (1970) 1.00
Response to methylphenidate in boys with attention-deficit hyperactivity disorder. Acta Paediatr (1999) 0.96
Inhibition of ongoing myeloma IgE synthesis in vitro by activated human T cells. J Immunol (1983) 0.95
In vitro effects of dichloroacetate and CO2 on hypoxic HeLa cells. Anticancer Res (2009) 0.92
Participation of an acidic group in the chymotrypsin catalysis. J Biochem (1969) 0.92
Selective reduction of cystine 1-8 in alpha-lactalbumin. Biochemistry (1973) 0.92
Cochlear action potentials in experimentally induced hypothyroidism in guinea pigs. Acta Otolaryngol Suppl (1975) 0.91
Expression of dendritic cells in ovarian tumors correlates with clinical outcome in patients with ovarian cancer. Hum Pathol (2001) 0.90
Changes in radical prostatectomy and radiation therapy rates for African Americans and whites. J Natl Med Assoc (2000) 0.90
Health-related quality of life in narcolepsy. Acta Neurol Scand (2006) 0.90
Purification of D-alanine carboxypeptidase from Escherichia coli B on a penicillin-Sepharose column. Biochem J (1975) 0.90
Isotype-specific human suppressor T cells for IgE synthesis activated by IgE-anti-IgE immune complexes. J Immunol (1984) 0.89
Periarticular inflammation, bilateral hilar adenopathy and a sarcoid reaction. Arthritis Rheum (1970) 0.89
Successful streptokinase therapy for catheter-induced subclavian vein thrombosis. Arch Intern Med (1980) 0.87
Immunobiology of the Dunning R-3327 rat prostate adenocarcinoma sublines: plasma and tumor effusion prostaglandins. Am J Reprod Immunol Microbiol (1985) 0.87
A genetic analysis of the Werner syndrome region on human chromosome 8p. Genomics (1993) 0.87
Impaired monocyte function in liver cirrhosis. Lancet (1979) 0.87
Renal cell carcinoma: the size variable. J Surg Oncol (1993) 0.86
Visual methods for the nanomolar detection of electrophilic reagents. J Biochem Biophys Methods (1983) 0.86
D-alanine carboxypeptidase from Streptococcus faecalis. Biochem Biophys Res Commun (1974) 0.85
Oligosaccharide synthesis on a light-sensitive solid support. I. The polymer and synthesis of isomaltose (6-O-alpha-D-glucopyranosyl-D-glucose). J Am Chem Soc (1973) 0.84
Specific cleavage of peptides at cysteinyl residues. J Am Chem Soc (1966) 0.84
Solitary renal calix. JAMA (1978) 0.83
An evaluation of the markers p53 and Ki-67 for their predictive value in prostate cancer. J Surg Oncol (1998) 0.82
Addition of iodine isocyanate to olefins. Scope and synthetic utility. J Org Chem (1967) 0.81
Use of polymers as chemical reagents. II. Synthesis of bradykinin. J Am Chem Soc (1968) 0.81
The proliferative response of hela cells to 2-deoxy-D-glucose under hypoxic or anoxic conditions: an analogue for studying some properties of in vivo solid cancers. Anticancer Res (2007) 0.81
Malacoplakia of the prostate. South Med J (1977) 0.81
An evaluation of five tests to diagnose prostate cancer. Prog Clin Biol Res (1987) 0.81
Effect of an enzyme dentifrice on caries. A two-year clinical pilot study. Swed Dent J (1979) 0.81
Report of 337 patients with renal cell carcinoma emphasizing 110 with stage IV disease and review of the literature. J Surg Oncol (1997) 0.81
Bone scan as a stratification variable in advanced prostate cancer. Cancer (1991) 0.80
Combination therapy using polyamine synthesis inhibitor alpha-difluoromethylornithine and adriamycin in treatment of rats carrying the Dunning R3327 MAT-LyLu prostatic adenocarcinoma. Prostate (1987) 0.79
Normoxic or hypoxic CD44/CD41 a₂ B₁ integrin-positive prostate PC3 cell side fractions and cancer stem cells. Med Oncol (2013) 0.79
An immunohistologic characterization of human prostatic atypical hyperplasia. Urol Res (1990) 0.79
A qualitative analysis of acidic proteins associated with regressing, growing, or dividing rat ventral prostate cells. Prostate (1983) 0.79
Paclitaxel is more effective than thalidomide in inhibiting LNCaP tumor growth in a prostate cancer model. Methods Find Exp Clin Pharmacol (1998) 0.79
Use of a nonenzymatic cleavage reaction for the identification of exposed tyrosine residues in bovine pancreatic ribonuclease. Biochemistry (1972) 0.79
Antennal response and field attraction of the predator Elatophilus hebraicus (Hemiptera: Anthocoridae) to sex pheromones and analogues of three Matsucoccus spp. (Homoptera: Matsucoccidae). Bioorg Med Chem (1996) 0.79
Neuropeptides, mast cells and allergy: novel mechanisms and therapeutic possibilities. Clin Exp Allergy (1990) 0.79
The conversion of 3-monoazotyrosine to 3-aminotyrosine in peptides and proteins. Biochim Biophys Acta (1971) 0.79
Relationship of arachidonic acid metabolism to indomethacin-sensitive immunoregulatory function and lymphocyte PGE sensitivity in peripheral blood mononuclear cells of disseminated solid tumor cancer patients. J Immunopharmacol (1984) 0.78
Are cancer stem cells concentrated in more alkaline hypoxic regions of tumors? Med Hypotheses (2009) 0.78
The effect of androgen deprivation on malignant and benign prostate tissue. Med Oncol (1998) 0.78
(4-Hydroxy-3-nitro)benzylated polystyrene. An improved polymeric nitrophenol derivative for peptide synthesis. Eur J Biochem (1974) 0.78
Videotape tic counts in the assessment of Tourette's syndrome: stability, reliability, and validity. J Am Acad Child Adolesc Psychiatry (1994) 0.78
The effect of normoxia and hypoxia on a prostate (PC-3) CD44/CD41 cell side fraction. Anticancer Res (2011) 0.78
Effect of cyclophosphamide on leukocytic subset distributions in rats carrying the Dunning R3327-MAT-LyLu prostatic adenocarcinoma. Prostate (1987) 0.78
A pilot study of the relation of premorbid characteristics to behavior in dementia. J Gerontol Nurs (1997) 0.78
Photoreversible modulators of Escherichia coli beta-galactosidase. 1-Benzoyl-1-cyano-2-(4,5-dimethoxy-2-nitrophenyl)-ethene and 1,1-dicyano-2-(4,5-dimethoxy-2-nitrophenyl)-ethene. J Protein Chem (2000) 0.78
To what extent are the "sets" of biologic properties expressed by hypoxic cancer cells and by cancer "stem" cells equivalent, intersecting, disjoint or complementary? Some implications for the design of cancer therapies. Med Hypotheses (2006) 0.77
Does homeobox-related "positional" genomic information contribute to implantation of metastatic cancer cells at non-random sites? Anticancer Res (2007) 0.77
Outcome of a national Israeli cohort of pediatric systemic lupus erythematosus. Lupus (2007) 0.77
[Tourette syndrome in children. An analysis of everyday problems--neurology or emotional conflicts?]. Tidsskr Nor Laegeforen (1994) 0.77
The instability of membrane markers expressed by human monocytes and macrophages in culture. Immunobiology (1983) 0.77
Antitumor effect of CPT-11, a new derivative of camptothecin, against human prostate cancer (PC-3) in vitro and prostate rat tumor (AT-3) in vivo. Methods Find Exp Clin Pharmacol (1996) 0.77
Inhibition of Escherichia coli beta-galactosidase by 2-nitro-1-(4,5-dimethoxy-2-nitrophenyl) ethyl, a photoreversible thiol label. Biochim Biophys Acta (1996) 0.77
Sulfenylation of tryptophan-62 in hen egg-white lysozyme. Biochemistry (1972) 0.77
Effect of early and delayed difluoromethylornithine pretreatment upon cyclophosphamide chemotherapy. Clin Physiol Biochem (1990) 0.76
Do intra-tumor alkaline micro-regions represent additional therapeutically privileged sites? Med Hypotheses (2008) 0.76
Selective covalent binding of methionyl-containing peptides and proteins to water insoluble polymeric reagent and their regeneration. Biochemistry (1977) 0.76
Staging and survival of patients with renal cell carcinoma. Semin Surg Oncol (1994) 0.75
In-vivo expression of a C-type RNA virus in rat ventral prostate epithelial cells. Biochem Biophys Res Commun (1979) 0.75
Development of Hodgkin's disease in the course of liver cirrhosis and impaired monocyte function. Postgrad Med J (1984) 0.75
Selective chemical cleavage of tryptophanyl peptide bonds in peptides and proteins. Biochemistry (1972) 0.75
Renal cell carcinoma: comparison of the TNM and Robson stage groupings. J Surg Oncol (1995) 0.75
Use of sodium in liquid ammonia for cleavage of N-proline peptides. Biochim Biophys Acta (1965) 0.75
BCG in management of transitional cell carcinoma invasive to prostate. Urology (1989) 0.75
Prostatic ultrasound in follow-up of prostatic disease. Urology (1988) 0.75
Bropirimine as neoadjuvant therapy decreases residual disease and expression of markers PCNA and TGF-beta 1 in a rat orthotopic prostate adenocarcinoma. Methods Find Exp Clin Pharmacol (1997) 0.75
Characterization of cellular infiltrates in the rat urinary bladder following BCG and thiotepa intravesical therapy. J Surg Oncol (1991) 0.75
Peptide synthesis. Annu Rev Biochem (1974) 0.75
Bilateral orchiectomy in the management of stage D-2 prostate cancer. Int Surg (1993) 0.75
Acute changes in U937 nuclear Ca2+ preceding type 1 "apoptotic" programmed cell death due to MK 886. Anticancer Res (2004) 0.75
Methods of early diagnosis in genitourinary cancer. Cancer (1987) 0.75
Evaluation of cytokeratin markers to differentiate between benign and malignant prostatic tissue. J Surg Oncol (1989) 0.75
Survival of Mexican-American males with seminoma. Rev Invest Clin (1997) 0.75
The effect of BCG on thoracic duct lymphocytes. Immunol Invest (1992) 0.75
The reaction of asparagine, glutamine, and derivatives with phosgene. J Org Chem (1968) 0.75
Lymphocyte subsets in urologic cancer patients. Urol Res (1987) 0.75
BCG in the management of superficial bladder cancer. Prog Clin Biol Res (1989) 0.75
Immunopriming of tumor infiltrating lymphocytes with neoadjuvant cyclophosphamide. Immunol Invest (1993) 0.75
Administration of recombinant tumor necrosis factor to rats bearing the Dunning R3327 MAT-LyLu prostatic adenocarcinoma. Clin Physiol Biochem (1987) 0.75
Microsurgical approach to the abdominal thoracic duct in the rat: considerations in the collection of lymphocytes. Microsurgery (1992) 0.75
Suramin as adjuvant therapy with radical prostatectomy. Prostate (1996) 0.75
Paclitaxel, bropirimine and linomide: effect on growth inhibition in a murine prostate cancer model by different growth regulatory mechanisms. Methods Find Exp Clin Pharmacol (1998) 0.75
Definition of the pulmonary antibody response to ovalbumin following local challenge in systemically immunized rats. Proc Soc Exp Biol Med (1988) 0.75
Cytoreductive surgery impedes metastasis and enhances the immune response: a preliminary report. J Surg Oncol (1991) 0.75
Osteoporosis with pathologic hip fractures in major depression. J Geriatr Psychiatry Neurol (1990) 0.75